BEAM
Price
$23.44
Change
+$0.04 (+0.17%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.94B
45 days until earnings call
KRYS
Price
$148.22
Change
+$3.41 (+2.35%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
4.27B
44 days until earnings call
Ad is loading...

BEAM vs KRYS

Header iconBEAM vs KRYS Comparison
Open Charts BEAM vs KRYSBanner chart's image
Beam Therapeutics
Price$23.44
Change+$0.04 (+0.17%)
Volume$15.99K
Capitalization1.94B
Krystal Biotech
Price$148.22
Change+$3.41 (+2.35%)
Volume$3.9K
Capitalization4.27B
BEAM vs KRYS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. KRYS commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and KRYS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (BEAM: $23.40 vs. KRYS: $144.81)
Brand notoriety: BEAM and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 75% vs. KRYS: 87%
Market capitalization -- BEAM: $1.94B vs. KRYS: $4.27B
BEAM [@Biotechnology] is valued at $1.94B. KRYS’s [@Biotechnology] market capitalization is $4.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • KRYS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -12.69% price change this week, while KRYS (@Biotechnology) price change was -7.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

KRYS is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.27B) has a higher market cap than BEAM($1.94B). BEAM YTD gains are higher at: -5.645 vs. KRYS (-7.564). KRYS has higher annual earnings (EBITDA): 181M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. KRYS (588M). KRYS has less debt than BEAM: KRYS (7.48M) vs BEAM (162M). BEAM has higher revenues than KRYS: BEAM (350M) vs KRYS (242M).
BEAMKRYSBEAM / KRYS
Capitalization1.94B4.27B45%
EBITDA-160.83M181M-89%
Gain YTD-5.645-7.56475%
P/E RatioN/A83.37-
Revenue350M242M145%
Total Cash926M588M157%
Total Debt162M7.48M2,167%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKRYS
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
74%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 29 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.04%
CRSP - BEAM
70%
Closely correlated
+3.23%
NTLA - BEAM
62%
Loosely correlated
-2.99%
DNLI - BEAM
61%
Loosely correlated
+0.79%
PRME - BEAM
60%
Loosely correlated
+0.35%
RXRX - BEAM
59%
Loosely correlated
-0.31%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-1.11%
CLDX - KRYS
56%
Loosely correlated
+0.62%
BEAM - KRYS
47%
Loosely correlated
+0.04%
ALT - KRYS
45%
Loosely correlated
+1.98%
ACLX - KRYS
42%
Loosely correlated
-0.74%
RXRX - KRYS
42%
Loosely correlated
-0.31%
More